Now that this approval is in the bag, CLB can resume issuing sales and EPS guidance, which had been suspended due to the impending commencement of European trading (#msg-74694986—see bold-faced paragraph near bottom).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”